Close Menu
Home » Adaptive Biotechnologies Prices Public Offering of Stock

Adaptive Biotechnologies Prices Public Offering of Stock

Jan 24, 2020
|
staff reporter

NEW YORK – Immune cell sequencing firm Adaptive Biotechnologies said after the close of the market on Thursday that it is selling 8 million shares of common stock at $26.50 per share.

The firm is selling the shares on behalf of certain investors and will not receive any proceeds from the sale.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Metabolite Trail

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

Just a Few Changes...

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

Not Meeting Standards

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

Science Studies Examine Archaic Admixture in West Africans, Variant Linked to Cannabis Dependence Risk

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.

What's Popular?

In Business News

  1. Bio-Rad Laboratories Products Indirectly Infringe 10x Genomics Patents, USITC Confirms

  2. OncoDNA Closes $20.6M Funding Round

  3. Exact Sciences Q4 Revenues Up 107 Percent

  4. Exact Sciences Boosting Position in Cancer Dx Market Through M&A

    Premium

  5. Yourgene Health Gets Australian Approval for Chemotoxicity Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.